Sangamo Therapeutics SGMOQ
OTC SGMOQ
$0.11 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Sangamo Therapeutics (SGMOQ) Shares Outstanding (Diluted) (2019 - 2026)

Updated

Sangamo Therapeutics' Weighted Average Shares Outstanding (Diluted) was 389.62 million in Q1 2026, up 76.9% from 220.3 million a year earlier and up 39.0% from the prior quarter.

Analysis

Sangamo Therapeutics (SGMOQ) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends

For FY2025, Weighted Average Shares Outstanding (Diluted) at Sangamo Therapeutics came in at 280.2 million, up 38.9% from FY2024.

  • Weighted Average Shares Outstanding (Diluted) has now increased for six consecutive years, with a five-year compound annual growth rate of 15.8% (FY2020 to FY2025).
  • In earlier years, Weighted Average Shares Outstanding (Diluted) was 201.7 million in FY2024 (+15.6%), 174.44 million in FY2023 (+13.0%), 154.35 million in FY2022 (+6.8%) and 144.57 million in FY2021 (+7.5%).
  • The Q1 2026 figure marks the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q4 2019.
  • Compared with a year earlier, Weighted Average Shares Outstanding (Diluted) has increased for 22 straight quarters, with growth averaging 32.4% over the last eight quarters.
  • Across the past five years, year-over-year growth in Weighted Average Shares Outstanding (Diluted) ran from 2.2% in Q1 2022 to 76.9% in Q1 2026.
  • Per Business Quant data, SGMOQ's Weighted Average Shares Outstanding (Diluted) in the three quarters before Q1 2026 was 280.2 million (Q4 2025), 304.3 million (Q3 2025) and 257 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.45 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.96 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.56 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.25 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.75 Bn
10 Sangamo Therapeutics 45.57 Mn -70.94 Mn - 389.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 389.62 Mn
Dec 31, 2025 280.20 Mn
Sep 30, 2025 304.30 Mn
Jun 30, 2025 257.00 Mn
Mar 31, 2025 220.30 Mn
Dec 31, 2024 201.70 Mn
Sep 30, 2024 214.33 Mn
Jun 30, 2024 203.95 Mn
Mar 31, 2024 180.34 Mn
Dec 31, 2023 174.44 Mn
Sep 30, 2023 177.17 Mn
Jun 30, 2023 174.33 Mn
Mar 31, 2023 169.18 Mn
Dec 31, 2022 154.35 Mn
Sep 30, 2022 158.04 Mn
Jun 30, 2022 148.16 Mn
Mar 31, 2022 146.22 Mn
Dec 31, 2021 144.57 Mn
Sep 30, 2021 145.40 Mn
Jun 30, 2021 143.98 Mn
API Access

Sangamo Therapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY